Lupus (SLE) trials in Hong Kong

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

  Where

  Tuenmen

  Age

  18 years to 100 years

  People

  348 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06711887 · EU 2024-515280-60-00
• Phase 1Taking people
  A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

  Where

  Pok Fu Lam

  Age

  18 years to 70 years

  People

  72 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06916806 · EU 2024-519015-34-00
• No phaseTaking people
  The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis

  Where

  Hong Kong

  Age

  18 years to 80 years

  People

  50

  Run by

  The University of Hong Kong

  See details and how to joinNCT02954939
• Phase 2Taking people
  SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease

  Where

  Hong Kong

  Age

  18 years and over

  People

  150

  Run by

  The University of Hong Kong

  See details and how to joinNCT06155604
• No phaseTaking people
  Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

  Where

  Pok Fu Lam

  Age

  18 years and over

  People

  5,000 worldwide

  Run by

  Monash University

  See details and how to joinNCT03138941